Cargando…

GBP2 is a prognostic biomarker and associated with immunotherapeutic responses in gastric cancer

BACKGROUND: The interferon-induced protein known as guanylate-binding protein 2 (GBP2) has been linked to multiple different cancer types as an oncogenic gene. Although the role of GBP2 in cancer has been preliminarily explored, it is unclear how this protein interacts with tumor immunity in gastric...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yunfei, Pan, Jiadong, An, Fangmei, Chen, Ke, Chen, Jiawei, Nie, He, Zhu, Yanping, Qian, Zhengtao, Zhan, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544588/ https://www.ncbi.nlm.nih.gov/pubmed/37784054 http://dx.doi.org/10.1186/s12885-023-11308-0

Ejemplares similares

GBP2 as a potential prognostic biomarker in pancreatic adenocarcinoma
por: Liu, Bo, et al.
Publicado: (2021)

Formin protein FMNL1 is a biomarker for tumor-infiltrating immune cells and associated with well immunotherapeutic response
por: Lu, Guomin, et al.
Publicado: (2023)

Decreased SLC39A1 (Solute carrier family 39 member 1) expression predicts unfavorable prognosis in patients with early-stage hepatocellular carcinoma
por: Zhang, Qinglin, et al.
Publicado: (2021)

Dishevelled-Associated Activator of Morphogenesis 2 (DAAM2) Predicts the Immuno-Hot Phenotype in Pancreatic Adenocarcinoma
por: Zhang, Qinglin, et al.
Publicado: (2022)

PSMC2 is a Novel Prognostic Biomarker and Predicts Immunotherapeutic Responses: From Pancreatic Cancer to Pan-Cancer
por: Huang, Wei, et al.
Publicado: (2023)

GBP2 as a potential prognostic predictor with immune-related characteristics in glioma
por: Li, Ren, et al.
Publicado: (2022)

Murine Gbp1 and Gbp2 are ubiquitinated independent of Toxoplasma gondii infection
por: Encheva, Vesela, et al.
Publicado: (2018)

Subtyping of microsatellite stability colorectal cancer reveals guanylate binding protein 2 (GBP2) as a potential immunotherapeutic target
por: Wang, Haizhou, et al.
Publicado: (2022)

Significance of CD80 as a Prognostic and Immunotherapeutic Biomarker in Lung Adenocarcinoma
por: Feng, Wei, et al.
Publicado: (2023)

Pan-cancer analysis identifies YTHDF2 as an immunotherapeutic and prognostic biomarker
por: Liu, Weiwei, et al.
Publicado: (2022)

Role of GBP1 in innate immunity and potential as a tuberculosis biomarker
por: Shi, Ting, et al.
Publicado: (2022)

Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma
por: Huang, Jiacheng, et al.
Publicado: (2021)

N6-methyladenosine-related non-coding RNAs are potential prognostic and immunotherapeutic responsiveness biomarkers for bladder cancer
por: Lu, Miaolong, et al.
Publicado: (2021)

BASP1 is a prognostic biomarker associated with immunotherapeutic response in head and neck squamous cell carcinoma
por: Pan, Xue, et al.
Publicado: (2023)

Potential prognostic and immunotherapeutic value of calponin 1: A pan-cancer analysis
por: Zhou, Hengli, et al.
Publicado: (2023)

Bioinformatics analysis of the prognostic and immunotherapeutic significance of NPRL2 in stomach adenocarcinoma
por: Pi, Yilin, et al.
Publicado: (2022)

Hsa_Circ_0066351 Acts as a Prognostic and Immunotherapeutic Biomarker in Colorectal Cancer
por: Gao, Yan, et al.
Publicado: (2022)

A potential immunotherapeutic and prognostic biomarker for multiple tumors including glioma: SHOX2
por: Wu, Xiaocong, et al.
Publicado: (2023)

The tumor microenvironment in gastrointestinal adenocarcinomas revealed a prognostic and immunotherapeutic biomarker
por: Zhang, Yong, et al.
Publicado: (2022)

IMPACT: A web server for exploring immunotherapeutic predictive and cancer prognostic biomarkers
por: Liu, Yutao, et al.
Publicado: (2023)

LPS-aggregating proteins GBP1 and GBP2 are each sufficient to enhance caspase-4 activation both in cellulo and in vitro
por: Dickinson, Mary S., et al.
Publicado: (2023)

Prognostic Value of Autophagy-related Proteins in Human Gastric Cancer
por: Wu, Minmin, et al.
Publicado: (2020)

Integrated bioinformatics analysis for conducting a prognostic model and identifying immunotherapeutic targets in gastric cancer
por: Liu, YaLing, et al.
Publicado: (2023)

Observatory wins GBP 10.6m contract
por: Dalton, A W
Publicado: (2003)

Space explorers get GBP35m boost
Publicado: (2002)

Whole exome capture in solution with 3 Gbp of data
por: Bainbridge, Matthew N, et al.
Publicado: (2010)

Upregulation of GBP1 in thyroid primordium is required for developmental thyroid morphogenesis
por: Yang, Rui-Meng, et al.
Publicado: (2021)

SLC31A1 Identifying a Novel Biomarker with Potential Prognostic and Immunotherapeutic Potential in Pan-Cancer
por: Zhang, Pei, et al.
Publicado: (2023)

Integrative analyses identify CD73 as a prognostic biomarker and immunotherapeutic target in intrahepatic cholangiocarcinoma
por: Sun, Bao-Ye, et al.
Publicado: (2023)

Pan-cancer analysis shows that IBSP is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including osteosarcoma
por: Pan, Boyu, et al.
Publicado: (2023)

C57BL/6 and 129 inbred mouse strains differ in Gbp2 and Gbp2b expression in response to inflammatory stimuli in vivo
por: Clough, Barbara, et al.
Publicado: (2019)

CC Chemokine Receptors in Lung Adenocarcinoma: The Inflammation-Related Prognostic Biomarkers and Immunotherapeutic Targets
por: Liu, Fangteng, et al.
Publicado: (2021)

Novel Immunotherapeutic Strategies of Gastric Cancer Treatment
por: Amedei, Amedeo, et al.
Publicado: (2011)

Leaf going nuclear in GBP 2.5m contract
Publicado: (2001)

Human GBP1 Is Involved in the Repair of Damaged Phagosomes/Endolysosomes
por: Buijze, Hellen, et al.
Publicado: (2023)

Systematic Characterization of Prognostic Values of Peroxiredoxin Family in Gastric Cancer
por: Xu, Rui, et al.
Publicado: (2020)

Oncolytic herpes simplex virus armed with a bacterial GBP1 degrader improves antitumor activity
por: Xie, Jun, et al.
Publicado: (2023)

Prognostic and Immunotherapeutic Roles of KRAS in Pan-Cancer
por: Yang, Kaixin, et al.
Publicado: (2022)

Pan-Cancer Analysis of the Prognostic and Immunotherapeutic Value of MITD1
por: Dong, Shiqiang, et al.
Publicado: (2022)

FMNL3 is Overexpressed in Tumor Tissues and Predicts an Immuno-Hot Phenotype in Pancreatic Cancer
por: Zhang, Qinglin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_aohcuht7rlgr3tpglh5e5a9vbr